TARA Biosystems, the biotech startup that’s using in vitro biology to accelerate drug development for cardiac diseases, has raised $10M in Series A funding from investors that include Partnership Fund for New York City, Alexandria Venture, Lifeforce Capital, DEFTA Partners, New York Ventures, Merieux Equity Partners, Trancos Ventures, Tachyon Ventures, and OMX Ventures. Founded by Boyang Zhang, Gordana Vunjak-Novakovic, Kacey Ronaldson, Milica Radisic, and Yimu Zhao in 2014, TARA Biosystems has now raised a total of $21.3M in reported equity funding.
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the New York business community and beyond. Find out more here.